Les chromosomes marqueurs surnuméraires (CMS) sont définis comme des chromosomes de structure anormale qui ne peuvent pas être identifiés ni caractérisés de façon non ambigüe par les techniques de cytogénétique conventionnelle seules et qui sont de taille égale ou plus petits qu’un chromosome 20 de la même métaphase. La prévalence de cette anomalie chromosomique est estimée à 0,071% en post-natal, 0,075% en diagnostic prénatal et 0,288% chez les patients atteints de retard mental et/ou du développement. Chez les patients infertiles, la fréquence des CMS est estimée à 0,122% et varie selon le sexe. Les CMS sont sans conséquence clinique dans 70% des cas. Dans un tiers des cas, ils peuvent être responsables de nombreuses anomalies du développement et de la reproduction humaine. A ce jour, il existe très peu d’études de caractérisation des CMS permettant une cartographie précise des gènes présents. Dans ce travail, nous avons étudié une série de huit CMS par cytogénétique conventionnelle, FISH (fluorescent in situ hybridization) et CGH array (array comparative genomic hybridization). Nous avons établi une cartographie des gènes présents dans ces CMS. L’étude de la relation génotype-phénotype des patients nous a permis de proposer l’implication de certains gènes candidats dans des anomalies du développement et de la reproduction humaine. Notre étude de l’implication des CMS dans les anomalies du développement humain s’est basée sur l’étude cytogénétique de trois fœtus. Les deux premiers fœtus étaient porteurs d’un CMS(20) en anneau. Le sujet 1 présentait un retard de croissance intra-utérin (RCIU) et une dysmorphie cranio-faciale. Le sujet 2 n’avait pas d’anomalies particulières à part une obésité diagnostiquée à l’âge de quatre mois. La taille de ces CMS(20) était de 13,6 Mb pour le sujet 1 et 4,8 Mb pour le sujet 2. Le gène SSTR4 présent sur le CMS(20) du sujet 2 code pour un récepteur de la somatostatine. Cette hormone joue un rôle dans le comportement alimentaire. Le troisième fœtus présentait un hygroma kystique et un RCIU associé à un CMS(13) néocentromérique. Les explorations par CGH array ont révélé un gain chromosomique de la région 13q21.1qter de 39 Mb contenant 80 gènes dont GPC5, GPC6, SPRY2, EFNB2, SOX1 et DZIP1. La modification d’expression de ces gènes est susceptible d’être responsable du phénotype des sujets étudiés.Notre étude de l’implication des CMS dans les anomalies de la reproduction humaine s’est basée sur l’étude cytogénétique de cinq patients qui présentaient des troubles de la fertilité (anomalies de la spermatogenèse, insuffisance ovarienne prématurée, syndrome des ovaires polykystiques et fausses couches spontanées). Les CMS explorés par CGH array correspondaient aux régions chromosomiques 15q11.2 (3,6 Mb), 21p11.2 (0,266 Mb), 6p11.2q12 (9 Mb) et 20p11.21 (3,3 Mb). Le CMS d’une des patientes ne contenait pas d’euchromatine et une autre patiente était porteuse de deux CMS d’origines chromosomiques différentes. Plusieurs gènes candidats (POTE B, BAGE et THBD) ont pu être identifiés. La modification de leur expression ainsi que des effets mécaniques ou biochimiques perturbant la méiose et la maturation des gamètes pourraient être responsables des troubles de la fertilité observés chez ces patients. L’étude des CMS par CGH array nous a permis de caractériser précisément les points de cassure des CMS, leur taille et leur composition génétique afin de cartographier les gènes présents dans les CMS et d’établir des relations entre le génotype et le phénotype des patients. / Small supernumerary marker chromosomes (sSMC) are defined as structurally abnormal chromosomes which cannot be unambiguously identified or characterized by conventional banding cytogenetic techniques alone and are generally equal in size or smaller than a chromosome 20 of the same metaphase spread. sSMC frequency is estimated at 0.071% in postnatal cases, 0.075% in prenatal cases, and 0.288% for mentally and/or development retarded patients. In infertile patients cases, sSMC frequency is estimated at 0.122% and is different in male (0.165%) and female infertility (0.022%). sSMC have no clinical consequences in 70% of the cases. In one third of the cases, they can be responsible for various human development and reproduction anomalies. To date, only a few studies precisely characterizing the sSMC contents have been performed.In this study, we used conventional cytogenetics, FISH (fluorescent in situ hybridization) and array CGH (array comparative genomic hybridization) to characterize eight sSMC and to precisely localize the genes included. The study of the genotype-phenotype correlations of the patients led us to suppose the implication of some candidate genes in human development and reproduction anomalies.Our study of the implication of sSMC in human development anomalies was based on the cytogenetic study of three fetuses. The first two fetuses carried a ring sSMC(20). Case 1 presented with intrauterine growth retardation and craniofacial dysmorphism. Case 2 had a normal phenotype except for obesity diagnosed at the age of four months. The size of these sSMC(20) was approximately 13,6 Mb for case 1 and 4,8 Mb for case 2. The SSTR4 gene located on the case 2 sSMC(20) is coding for one of the somatostatin receptor. This hormone has multiple effects on variable cells and is implicated in the regulation of food behavior, which could explain the obesity of case 2. Case 3 presented with intrauterine growth retardation and a cystic hygroma associated with a neocentric sSMC(13). Array CGH investigations showed a 32.9 Mb gain from 13q31.1 to 13qter region containing 80 genes. Among these genes, six genes could be involved in the phenotype of the proband (GPC5, GPC6, SPRY2, EFNB2, SOX1 and DZIP1). The expression modification of these genes could be responsible for the phenotype observed.Our study of the implication of sSMC in human reproduction anomalies was based on the cytogenetic study of five patients presenting fertility troubles (spermatogenesis impairment, ovarian insufficiency, polycystic ovary syndrome and repeated abortions). The sSMC explored by array CGH corresponded to the 15q11.2 region (3.6 Mb), the 21p11.2 region (0.266 Mb), the 6p11.2q12 region (9 Mb) and 20p11.21 region (3.3 Mb). The sSMC of one of the patients did not contain euchromatin and one patient carried two sSMC derived from two different chromosomes. Among the genes present on the sSMC, some candidate genes (POTE B, BAGE and THBD) have been identified. The modification of their expression and mechanical or biochemical effects of the sSMC impeding meiosis could be directly responsible for the fertility trouble observed in these patients. A detailed molecular cytogenetic investigation using array CGH allowed us to precisely characterize the chromosomal breakpoints, the size and genomic constitution of sSMC. This study may be helpful to address genotype–phenotype correlations and for medical and genetic counseling.

Thèse doctorat : Aspects moléculaires et Cellulaires de la Biologie : Strasbourg 1 : 2006. / Thèse soutenue sur un ensemble de travaux. Titre provenant de l'écran-titre. Bibliogr. 11 p.

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 6 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 4 uppsatser.

Many genetic diseases or abnormalities that may occur in human chromosomes can be detected by analyzing the shape and morphology of chromosomes. The elaboration of the karyotype (organization of the 24 chromosomes of a human cell according to its size through a drawing or a photograph obtained from a microscope) is usually used to achieve this goal. The first steps for chromosomal analysis is the definition and extraction of morphology and banding pattern (gray level variations along its length) features of chromosomes. Among the morphological characteristics, in addition to its size, there is the centromere location (a region that divides the chromosome in long arm and short arm) and the classification according to the same. The advances made in cell culture techniques, banding, collecting and analyzing of materials for the implementation of the karyotype allowed great progress in the diagnosis of chromosomal abnormalities. However, this process is still used manually, because despite the growing demand of this type of examination, it is still small the supply of automated systems that help the geneticists work in the katyotype generation. So, the automation of this process and the possibility of obtaining results in a short time speeding therapeutic conduct and reassuring that families are invaluable. Centromere detection is of great importance both in the manual process as the automatic process, for faster diagnosis. In the manual process, the possibility of performing a grouping of the chromosomes in relation to the size and centromere position would help the geneticist work at the identification and also in segmentation, because by defining the chromosome classification in relation to its centromere position, is possible to define their polarity (putting the chromosome "standing"). In the automatic process, it s an excellent filter in the search for a higher correctness rate for chromosomes identification systems, because each type of chromosome always belongs to a particular classification according to the centromere (metacentric, submetacentric or acrocentric). In this dissertation, therefore, sought to develop a series of methods for centromere detection, especially the definition of two algorithms that use the methods developed in this work. As a result it is emphasized that in applying this approach on the image base used from BioImLab (Biomedical Imaging Laboratory, University of Padova, Italy), it achieves about 94.37% of correctness, a higher rate than any work related literature. / Muitas doenças genéticas ou anomalias que podem ocorrer nos cromossomos humanos podem ser descobertas através da análise da forma e das características morfológicas dos cromossomos. A elaboração do cariótipo (organização dos 24 cromossomos de uma célula humana de acordo com o seu tamanho através de um desenho ou de uma fotografia obtida de um microscópio) é geralmente utilizada para alcançar este objetivo. Os primeiros passos para as análises cromossômicas são a definição e extração das características morfológicas e do padrão de bandas dos cromossomos (variações dos níveis de cinza ao longo de seu comprimento). Dentre as características morfológicas, além do seu tamanho, destaca-se a localização do centrômero (local que divide o cromossomo em braço longo e braço curto) e a classificação de acordo com o mesmo. Os avanços ocorridos nas técnicas de cultura celular, bandeamento, coleta e análise dos materiais para a execução do cariótipo possibilitaram grandes progressos no diagnóstico das alterações cromossômicas. Porém, este processo ainda é bastante utilizado de forma manual, pois, apesar da demanda crescente deste tipo de exame, ainda é pequena a oferta de sistemas automáticos que auxiliem o trabalho dos geneticistas na geração do cariótipo. Logo, a automatização deste processo e a possibilidade de se obter resultado em curto espaço de tempo, agilizando condutas terapêuticas ou tranqüilizando familiares tem um valor inestimável. A detecção do centrômero é de grande importância tanto no aspecto do processo manual como no processo automático, pois agilizaria o diagnóstico. No processo manual, a possibilidade de se realizar um agrupamento dos cromossomos em relação ao tamanho e a posição do centrômero auxiliaria o trabalho de um geneticista na parte de identificação e também na segmentação, pois ao se definir a classificação de um cromossomo em relação a sua posição do centrômero, é possível definir a sua polaridade (colocar o cromossomo em pé ). No processo automático, é um excelente filtro na busca por uma maior taxa de acertos nos sistemas de identificação dos cromossomos, pois cada tipo de cromossomo pertencerá sempre a uma determinada classificação de acordo com o centrômero (metacêntrico, submetacêntrico ou acrocêntrico). Nesta dissertação, portanto, buscou-se desenvolver uma série de métodos para detecção do centrômero, destacando-se a definição de dois algoritmos que utilizam os métodos desenvolvidos no decorrer deste trabalho. Como resultado obtido destaca-se que ao aplicar esta abordagem na base de imagens utilizada do BioImLab (Laboratório de Imagem Biomédica, Universidade de Padova, Itália), alcança-se cerca de 94.37% de acertos, uma taxa maior que qualquer trabalho relacionado na literatura.

Orientadores: Katia Borgia Barbosa Pagnano, Afonso Celso Vigorito / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas / Made available in DSpace on 2018-08-14T18:14:56Z (GMT). No. of bitstreams: 1 Machado_MelissaPereira_M.pdf: 1144638 bytes, checksum: c55a80d3cce151782b16b741b0f21149 (MD5) Previous issue date: 2009 / Resumo: A leucemia mieloide crônica (LMC) e uma desordem mieloproliferativa caracterizada pela presença do cromossomo Philadelphia (Ph), resultado da fusão do gene abl e do gene bcr cujo produto e uma proteína de atividade de tirosina quinase, inibida pelo mesilato de imatinibe. O imatinibe e hoje o tratamento de primeira linha da LMC e o monitoramento molecular dos transcritos BCR-ABL e fundamental no acompanhamento dos pacientes e na detecção precoce da perda de resposta ao tratamento. O objetivo deste trabalho foi realizar a padronização do método de PCR quantitativo (RQPCR) para o monitoramento molecular dos transcritos BCR-ABL de pacientes com LMC em tratamento com imatinibe. Foram coletadas amostras de sangue periferico de pacientes com LMC para RQ-PCR ao diagnostico e a cada três meses apos o tratamento com imatinibe. Foi utilizado o método Taqman. Como gene controle foi utilizado o ABL. Foi criada uma curva standard com diluições de 108 a 103 de um plasmideo com os transcritos b3a2 e b2a2 e com ABL. As quantificações foram feitas em duplicatas, assim como a curva standard. O threshold utilizado foi de 0,05 e a eficiência foi determinada em 99%. Os resultados foram reportados como uma relação entre BCR-ABL/ABL. Para o valor de referencia basal do laboratório foram analisadas 30 amostras de pacientes ao diagnostico, e calculada a mediana, sendo esse valor 83,66%. Resposta molecular maior (RMM) foi definida como redução dos transcritos BCR-ABL em 3 log a partir do valor basal do laboratório. Os valores foram ajustados a escala internacional, usando-se um fator de conversão de 1.19. Apos a padronização do método, foram avaliados 60 pacientes com LMC, cujas amostras foram coletadas ao diagnostico e a cada 3 meses. Respostas hematológica, citogenetica maior e citogenetica completa foram obtidas em 57 (95%), 45 (75%) e 38 (63%) dos pacientes, respectivamente. Vinte e quatro de 60 pacientes atingiram a RMM (40%), numa mediana de 8,5 meses. A sobrevida global foi superior nos pacientes com RCC (100%) vs pacientes sem RCC (77%) em 48 meses. Pacientes com RCC e com RMM tiveram uma sobrevida livre de eventos superior em relação aos pacientes que não atingiram os dois tipos de reposta (100% vs 60% respectivamente) (p= 0.007). Em resumo, neste estudo demonstramos o impacto prognostico em atingir RCC e RMM e também a importância do acompanhamento molecular nos pacientes com LMC. / Abstract: Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the presence of Philadelphia chromosome (Ph), the result of bcr and abl gene fusion, which product is a protein with kinase activity, inhibited by imatinib. Imatinib is currently the first-line treatment of CML and molecular monitoring of BCRABL transcripts is essential in monitoring of patients and for the early detection of loss of response to treatment. The aim of this study was to standardize quantitative PCR (RQ-PCR) method for molecular monitoring of BCR-ABL transcripts in patients with CML treated with imatinib. Peripheral blood samples from chronic phase patients were collected for RQ-PCR at diagnosis and every three months after treatment with imatinib. Taqman method was used for RQ-PCR. A standard curve with dilutions of 108 to 103 of a plasmid with the b3a2 and b2a2 transcripts and ABL gene, used as the control gene, was constructed. The runs were made in duplicates. The threshold used was 0.05 and the efficiency was determined as 99%. The results were reported as a BCR-ABL/ABL ratio (%). For the reference value of the baseline of the laboratory 30 samples from patients at diagnosis were quantified and the median value calculated was 83.66%. Major molecular response (MMR) was considered a three log reduction from the baseline value. MMR values were adjusted to international scale, using a conversion factor of 1.19. After standardization, BCR-ABL levels of 60 CML patients in chronic phase treated with imatinib were measured at diagnosis and then every three months. Hematological, major cytogenetic and complete cytogenetic responses were achieved in 57 (95%), 45 (75%) and 38 (63%) patients, respectively. Twenty-four out of 60 patients achieved a MMR (40%), in a median time of 8.5 months. Overall survival was superior for patients with CCR (100%) versus patients with no CCR (77%) (p= 0.01) in 48 months. Patients with CCR and with MMR had a superior event free-survival (EFS) in comparison with patients with CCR and no MMR (p= 0.007). In conclusion, we could demonstrate the prognostic impact of achieving CCR and a major molecular response and also the importance of molecular monitoring in the follow-up of CML patients. / Mestrado / Ciencias Medicas / Mestre em Clinica Medica

Les systèmes toxine-antitoxine (TA) bactériens ont été découverts il y a une vingtaine d’année sur les plasmides à bas nombre de copie. Ils sont composés de deux gènes organisés en opéron, l’un codant pour une toxine stable et l’autre pour une antitoxine instable capable de neutraliser l’effet de la toxine. Les systèmes TA sont fortement représentés au sein de l’ensemble des génomes bactériens. Ils se localisent aussi bien sur des éléments génétiques mobiles (plasmides, phages, transposons,…) que dans les chromosomes, ce qui suggère que le transfert horizontal de gènes participe à leur dissémination. Le système TA ccd du plasmide F d’Escherichia coli (ccdF) est composé de l’antitoxine CcdA et de la toxine CcdB. Le système ccdF contribue à la stabilité du plasmide F en tuant les bactéries-filles n’ayant pas reçu de copies plasmidiques lors de la division bactérienne (tuerie post-ségrégationelle).<p>Au cours de ce travail, nous avons caractérisé un homologue du système toxine-antitoxine ccd du plasmide F (ccdF) qui se situe dans le chromosome de la souche pathogène E. coli O157:H7 EDL933 entre les gènes folA et apaH (ccdO157). Les systèmes ccdF et ccdO157 coexistent naturellement dans les souches d’E. coli O157:H7, le système ccdF se trouvant sur le plasmide pO157 qui dérive du plasmide F. Nos résultats montrent que l’antitoxine plasmidique CcdAF neutralise l’effet de la toxine chromosomique CcdBO157, tandis que l’antitoxine chromosomique CcdAO157 ne contrecarre pas la toxicité de la toxine plasmidique CcdBF. Nous avons également montré que le système ccdF cause une tuerie post-ségrégationelle, lorsqu’il est cloné dans un plasmide instable, dans une souche possédant le système chromosomique ccdO157. Le système ccdF est donc fonctionnel en présence de son homologue chromosomique. <p>Le système ccdO157 est absent du chromosome de la souche de laboratoire E. coli K-12 MG1655, où une région intergénique de 77 pb sépare les gènes folA et apaH. Celle-ci contient une séquence cible pour la transposition. Nous avons étudié la distribution du système ccdO157 au sein de 523 souches d’E. coli représentatives de l’ensemble des sérogroupes décrits. Nos résultats montrent que le système ccdO157 est présent au sein de souches appartenant à 47 sérogroupes différents. Nos résultats mettent en évidence la diversité de la région intergénique folA-apaH d’E. coli. Celle-ci peut contenir gènes codant pour des protéines présentant de l’homologie avec des protéines d’espèce bactériennes éloignées d’E. coli ou d’organismes eucaryotes, ainsi qu’un élément génétique mobile, l’IS621, ce qui montre que le système ccdO157 a intégré le chromosome d’E. coli via le transfert horizontal de gènes.<p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished

Les systèmes toxine-antitoxines (TA) sont abondants dans la majorité des génomes bactériens séquencés à ce jour. Ces systèmes codent une toxine stable qui inhibe soit la transcription, soit la traduction, et une antitoxine qui contrecarre l’effet de la toxine par formation d’un complexe avec celle-ci. L’antitoxine est instable suite à sa dégradation continue par les protéases ATP-dépendantes. Afin de maintenir un ratio antitoxine :toxine constant en condition normale de croissance, l’expression des systèmes TA est régulée négativement au niveau transcriptionnel par le complexe toxine-antitoxine.<p><p>Au début de notre travail, cinq systèmes TA étaient identifiés dans le chromosome d’E. coli. Il avait été montré par notre laboratoire que parmi ces systèmes, seul yefM-yoeB était activé en condition de surproduction de la protéase ATP-dépendante Lon. Ce résultat était surprenant puisque Lon était connue pour dégrader également l’antitoxine RelB du système chromosomique relBE. Un des objectifs de notre travail était de comprendre les mécanismes sous-jacents à cette spécificité. Nous avons montré que l’antitoxine YefM était dégradée à la fois par Lon et les protéases ClpAP et ClpXP. Nous avons également montré qu’en condition de surproduction de Lon, YefM était fortement instable (t1/2~ 10 min. vs 60 min en condition normale). Cette instabilité accrue permet donc l’activation du système yefM-yoeB, c’est-à-dire la libération de la toxine YoeB du complexe qu’elle forme avec YefM. Nous avons également avons montré que le t1/2 de RelB n’était pas affecté par la surproduction de Lon, ce qui explique pourquoi le système relBE n’est pas activé dans ces conditions. Notre hypothèse était qu’un cofacteur soit nécessaire à la dégradation de RelB par Lon et que celui-ci serait limitant dans nos conditions expérimentales. Le crible génétique que nous avons réalisé n’a cependant pas permis d’identifier de cofacteur de dégradation ni de régulateur transcriptionnel en trans du système relBE. <p><p>Un deuxième volet de notre travail de thèse a consisté en l’étude de la fonction des systèmes TA chromosomiques. L’hypothèse prévalente au début de notre travail était que les systèmes TA soient intégrés dans les voies adaptatives de réponses au stress. Cependant, le résultat de leur activation était controversé. L’hypothèse du groupe de Gerdes était que leur activation mène à un état bactériostatique réversible alors que le groupe d’Engelberg-Kulka montrait que le système mazEF était un système de mort programmée. Afin d’éclaircir le rôle des cinq systèmes TA dans la physiologie d’E. coli, nous avons testé l’effet de nombreux stress sur la croissance et la viabilité de souches sauvages et de souches délétées de ces systèmes. Aucune des conditions que nous avons testées n’a entraîné une diminution de la viabilité excluant de manière définitive l’hypothèse de la mort programmée. De plus, l’inhibition de croissance causée par ces différents stress s’est avérée être indépendante des cinq systèmes, de même que la phase de récupération suivant les différents stress. Enfin, nos expériences de compétition ont clairement démontré que les cinq systèmes ne procuraient aucun avantage sélectif aux bactéries dans des conditions de compétition en carence nutritive. Les systèmes TA étudiés dans ce travail ne jouent donc aucun rôle dans l’adaptation aux stress que nous avons testé puisqu’ils n’améliorent ni l’aptitude (fitness), ni la compétitivité des bactéries dans ces conditions. <p><p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished

Squamate reptiles in general possess an unusual variability in karyotype and sex determining mechanisms. However, in these two aspects, iguanas (Pleurodonts) are considered as a relatively conservative group of lizards. So far only genotypic sex determination with male heterogamety has been detected in this lineage. However, the sex chromosomes have not been revealed in many species by classical cytogenetics, probably due to their homomorphy. Significant variability in karyotype was observed only in the species-rich genera Anolis, Sceloporus and Liolaemus. The aim of this thesis was to investigate the genome of available species from the main iguanid lineages using classical and molecular cytogenetic methods. As well as finding the karyotype characteristics, which may represent synapomorphies of main iguanid lineages, the other aim was to try to identify sex chromosomes. This study confirmed previously published karyotypes of 13 species and established new descriptions of karyotype for eight species. The chromosomes of all studied specimens were examined by methods of classical and molecular cytogenetics, 21 species covering eight iguanid families were analysed in this thesis. The majority of studied species shared the apparently ancestral karyotype of the group, with diploid chromosome number...

Eukaryotic DNA is packaged in chromatin, whose repeating subunit, the nucleosome, consists of an octamer of histone proteins wrapped by about 147bp of DNA. This packaging affects the accessibility of DNA and hence any process that occurs on DNA, such as replication, repair, and transcription. An early observation from genome-wide nucleosome mapping in yeast was that genes had a surprisingly characteristic structure, which has motivated studies to understand what determines this architecture. Both sequence and trans acting factors are known to influence chromatin packaging, but the relative contributions of cis and trans determinants of nucleosome positioning is debated. Here we present data using genetic approaches to examine the contributions of cis and trans acting factors on nucleosome positioning in budding yeast. We developed the use of yeast artificial chromosomes to exploit quantitative differences in the chromatin structures of different yeast species. This allows us to place approximately 150kb of sequence from any species into the S.cerevisiae cellular environment and compare the nucleosome positions on this same sequence in different environments to discover what features are variant and hence regulated by trans acting factors. This method allowed us to conclusively show that the great preponderance of nucleosomes are positioned by trans acting factors. We observe the maintenance of nucleosome depletion over some promoter sequences, but partial fill-in of NDRs in some of the YAC v promoters indicates that even this feature is regulated to varying extents by trans acting factors. We are able to extend our use of evolutionary divergence in order to search for specific trans regulators whose effects vary between the species. We find that a subset of transcription factors can compete with histones to help generate some NDRs, with clear effects documented in a cbf1 deletion mutant. In addition, we find that Chd1p acts as a potential “molecular ruler” involved in defining the nucleosome repeat length differences between S.cerevisiae and K.lactis. The mechanism of this measurement is unclear as the alteration in activity is partially attributable to the N-terminal portion of the protein, for which there is no structural data. Our observations of a specialized chromatin structure at de novo transcriptional units along with results from nucleosome mapping in the absence of active transcription indicate that transcription plays a role in engineering genic nucleosome architecture. This work strongly supports the role of trans acting factors in setting up a dynamic, regulated chromatin structure that allows for robustness and fine-tuning of gene expression.